Clinical Trial Update: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the effectiveness and safety of dapoxetine for premature ejaculation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• Dapoxetine (dapoxetine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED